Applications, hearings, determinations, etc.: Isotec Inc.,
[Federal Register: February 10, 1999 (Volume 64, Number 27)]
[Notices]
[Page 6681-6682]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr10fe99-124]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on November 30, 1998, Isotec Inc., 3858 Benner Road, Miamisburg, Ohio 45342, made application by renewal to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed below.
Drug
Schedule
Cathinone (1235)........................... I Methcathinone (1237)....................... I N-Ethylamphetamine (1475).................. I N,N-Dimethylamphetamine (1480)............. I Aminorex (1585)............................ I Methaqualone (2565)........................ I Lysergic acid diethylamide (7315).......... I Tetrahydrocannabinols (7370)............... I Mescaline (7381)........................... I 2,5-Dimethoxyamphetamine (7396)............ I 3,4-Methylenedioxyamphetamine (7400)....... I 3,4-Methylenedioxy-N-ethylamphetamine
I (7404). 3,4-Methylenedioxymethamphetamine (7405)... I 4-Methylamphetamine (7411)................. I Psilcoybin (7437).......................... I Psilocyn (7438)............................ I N-Ethyl-1-phenylcyclohexylamine (7455)..... I Dihydromorphine (9145)..................... I
[[Page 6682]]
Normorphine (9313)......................... I Acetylmethadol (9601)...................... I Alphacetylmethadol Except Levo-
I Alphacetylmethadol (9603). Normethadone (9635)........................ I 3-Methylfentanyl (9813).................... I Amphetamine (1100)......................... II Methamphetamine (1105)..................... II Methylphenidate (1724)..................... II Amobarbital (2125)......................... II Pentobarbital (2270)....................... II Secobarbital (2315)........................ II 1-Phenylcyclohexylamine (7460)............. II Phencyclidine (7471)....................... II Phenylacetone (8501)....................... II 1-Piperidinocyclohexanecarbonitrile (8603). II Codeine (9050)............................. II Dihydrocodeine (9120)...................... II Oxycodone (9143)........................... II Hydromorphone (9150)....................... II Benzoylecgonine (9180)..................... II Ethylmorphine (9190)....................... II Hydrocodone (9193)......................... II Isomethadone (9226)........................ II Meperidine (9230).......................... II Methadone (9250)........................... II Methadone intermediate (9254).............. II Dextropropoxyphene, bulk (non-dosage forms) II (9273). Morphine (9300)............................ II Levo-Alphacetylmethadol (9648)............. II Oxymorphone (9652)......................... II Fentanyl (9801)............................ II
The firm plans to use small quantities of the listed controlled substances to produce standards for analytical laboratories.
Any other such applicant and any person who is presently registered with DEA to manufacture such substances may file comments or objections to the issuance of the proposed registration.
Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, D.C. 20537, Attention: DEA Federal Register Representative (CCR), and must be filedno later than April 12, 1999.
Dated: January 27, 1999. John H. King, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. 99-3161Filed2-9-99; 8:45 am]
BILLING CODE 4410-09-M
